 Presentation and QA session scheduled for post-market on Monday, May 16, 2022 BOSTON , May 9, 2022 PRNewswire -- Ginkgo Bioworks NYSE: DNA, the leading horizontal platform for cell programming, announced today that it plans to host a presentation and QA session reviewing business performance for the first quarter ended March 31, 2022, on Monday, May 16, 2022, beginning at 4:30 p.m. ET. The presentation details and webcast link will be available on Ginkgos investor relations website at , and a replay will be made available. 